Inovio Pharmaceuticals, Inc.

NASDAQ: INO
$3.62
-$0.19 (-5.0%)
Real time price as of February 20, 2020 1:30 pm EST

Biotech Stocks Seeing the Biggest Boost From Coronavirus Outbreak

The story that has dominated this past week is that China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up. Global ...
Read Full Story »

Coronavirus Infections Climb Hand in Hand With These Biotech Stocks

China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up. Global infections of nearly 8,000 people have been reported, but only ...
Read Full Story »

12 Stocks Surging That Could Help Treat or Fight Coronavirus

Monday morning brought a huge sell-off in the market as more and more people are concerned about the growing impact of this new coronavirus. So far, over 2,800 cases and ...
Read Full Story »

As Coronavirus Spreads, Sensitive China, US, Global Economies Face Great Risks

The current coronavirus outbreak that originated in Wuhan in the Hubei province of China has become even more deadly and less contained. To add on more fears, there are now ...
Read Full Story »

Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies

The most recent coronavirus outbreak that originated in Wuhan in the Hubei province of China has become more deadly and is much less contained than global health officials would have ...
Read Full Story »

This Biotech Could Make a Big Splash With the Coronavirus Scare

The newest coronavirus out of China has resulted in a rising interest in biotechs that may be able to produce a vaccine or treatment with a short turnaround. We’ve seen ...
Read Full Story »

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in East Asia. Although less than 300 infections have been reported, there are ...
Read Full Story »

Is There a Method to Inovio Pharma’s Cost-Cutting Madness?

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares dipped on Wednesday after the company said that it was taking measures to cut costs and its overall burn rate. When a company says ...
Read Full Story »

Thursday’s Top 4 Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff. Although the sector is feeling the pinch from the ...
Read Full Story »

AstraZeneca Cuts Almost All Ties to Inovio Pharma

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca PLC (NASDAQ: AZN) would be scaled back. AstraZeneca subsidiary MedImmune is ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

Stocks were indicated to open higher on Tuesday as bond yields appear to be stabilizing after the yield curve inverted late last week. Investors need to consider how they want ...
Read Full Story »

5 Buy-Rated Stocks Under $5 With Massive Implied Upside Potential

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares ...
Read Full Story »

5 Sizzling Biotech Stocks Under $10 With Gigantic Upside Potential

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares ...
Read Full Story »

Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused ...
Read Full Story »

Is Inovio Pharma’s Zika Vaccine the Next Big Thing?

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) saw a handy gain early on Wednesday after the company gave an update on its Zika virus study. Specifically, Inovio said that its ...
Read Full Story »